A detailed history of Credit Suisse Ag transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Credit Suisse Ag holds 141,343 shares of ACAD stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
141,343
Previous 140,422 0.66%
Holding current value
$2.09 Million
Previous $4.4 Million 40.56%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$17.79 - $30.86 $16,384 - $28,422
921 Added 0.66%
141,343 $2.61 Million
Q4 2023

Feb 08, 2024

SELL
$20.78 - $31.77 $185,357 - $283,388
-8,920 Reduced 5.97%
140,422 $4.4 Million
Q3 2023

Nov 13, 2023

SELL
$20.84 - $33.47 $527,710 - $847,527
-25,322 Reduced 14.5%
149,342 $3.11 Million
Q2 2023

Aug 11, 2023

SELL
$17.8 - $25.65 $536,634 - $773,296
-30,148 Reduced 14.72%
174,664 $4.18 Million
Q1 2023

May 10, 2023

BUY
$16.32 - $20.92 $67,434 - $86,441
4,132 Added 2.06%
204,812 $3.85 Million
Q4 2022

Feb 13, 2023

BUY
$14.2 - $18.63 $328,176 - $430,557
23,111 Added 13.02%
200,680 $3.19 Million
Q3 2022

Nov 10, 2022

SELL
$14.11 - $18.27 $157,580 - $204,039
-11,168 Reduced 5.92%
177,569 $2.91 Million
Q2 2022

Aug 12, 2022

BUY
$13.01 - $27.22 $236,456 - $494,723
18,175 Added 10.66%
188,737 $2.66 Million
Q1 2022

May 16, 2022

SELL
$20.94 - $27.5 $127,713 - $167,722
-6,099 Reduced 3.45%
170,562 $4.13 Million
Q4 2021

Feb 14, 2022

SELL
$16.79 - $27.09 $1.09 Million - $1.76 Million
-64,933 Reduced 26.88%
176,661 $4.12 Million
Q3 2021

Nov 12, 2021

BUY
$15.78 - $24.77 $1.8 Million - $2.83 Million
114,340 Added 89.85%
241,594 $4.01 Million
Q2 2021

Aug 16, 2021

SELL
$19.4 - $27.42 $375,894 - $531,289
-19,376 Reduced 13.21%
127,254 $3.1 Million
Q1 2021

May 14, 2021

SELL
$25.02 - $54.99 $37,254 - $81,880
-1,489 Reduced 1.01%
146,630 $3.78 Million
Q4 2020

Feb 12, 2021

BUY
$41.04 - $56.79 $332,054 - $459,487
8,091 Added 5.78%
148,119 $7.92 Million
Q3 2020

Nov 13, 2020

SELL
$36.42 - $57.0 $5.79 Million - $9.06 Million
-159,025 Reduced 53.18%
140,028 $5.78 Million
Q2 2020

Aug 12, 2020

BUY
$39.26 - $52.73 $7.61 Million - $10.2 Million
193,958 Added 184.55%
299,053 $14.5 Million
Q1 2020

May 13, 2020

SELL
$31.65 - $46.87 $2.77 Million - $4.1 Million
-87,411 Reduced 45.41%
105,095 $4.44 Million
Q4 2019

Feb 12, 2020

SELL
$36.21 - $51.4 $1.36 Million - $1.92 Million
-37,437 Reduced 16.28%
192,506 $8.23 Million
Q3 2019

Nov 12, 2019

BUY
$22.22 - $44.01 $2.67 Million - $5.3 Million
120,375 Added 109.86%
229,943 $8.28 Million
Q2 2019

Aug 14, 2019

BUY
$23.32 - $28.12 $464,954 - $560,656
19,938 Added 22.24%
109,568 $2.93 Million
Q1 2019

May 14, 2019

SELL
$16.17 - $27.38 $36,156 - $61,221
-2,236 Reduced 2.43%
89,630 $2.41 Million
Q4 2018

Feb 13, 2019

BUY
$14.32 - $22.92 $238,671 - $382,007
16,667 Added 22.16%
91,866 $1.49 Million
Q3 2018

Nov 13, 2018

SELL
$13.03 - $21.81 $338,727 - $566,972
-25,996 Reduced 25.69%
75,199 $1.56 Million
Q2 2018

Aug 14, 2018

BUY
$15.07 - $22.34 $300,043 - $444,789
19,910 Added 24.49%
101,195 $1.55 Million
Q1 2018

May 15, 2018

SELL
$22.47 - $32.33 $49,434 - $71,126
-2,200 Reduced 2.64%
81,285 $1.83 Million
Q4 2017

Feb 14, 2018

SELL
$26.84 - $39.14 $3.8 Million - $5.54 Million
-141,500 Reduced 62.89%
83,485 $2.52 Million
Q3 2017

Nov 14, 2017

SELL
$29.49 - $38.37 $1.25 Million - $1.63 Million
-42,395 Reduced 15.86%
224,985 $8.47 Million
Q2 2017

Aug 14, 2017

BUY
N/A
267,380
267,380 $7.46 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.